Fuyuan Pharmaceutical: Ethyl Eicosapentaenoate Soft Capsules Obtain Drug Registration Certificate

People’s Financial News, March 23 — Fuyuan Pharmaceutical (601089) announced on March 23 that its wholly-owned subsidiary, Zhejiang Aisheng Pharmaceutical Co., Ltd., recently received a drug registration certificate from the National Medical Products Administration for Ethyl 20-Carbonyl-20-ene-1,2-diol soft capsules (specification: 1.0g), approving the production of this medication. The indication for this drug is: in conjunction with controlled diet, used to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL). According to relevant national policies, obtaining this drug registration certificate is considered equivalent to passing the consistency evaluation.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin